Depression of serotonin synaptic transmission by the dopamine Precursor L-DOPA

Stephanie C. Gantz, Erica S. Levitt, Nerea Llamosas, Kim Neve, John Williams

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Imbalance between the dopamine and serotonin (5-HT) neurotransmitter systems has been implicated in the comorbidity of Parkinson's disease (PD) and psychiatric disorders. L-DOPA, the leading treatment of PD, facilitates the production and release of dopamine. This study assessed the action of L-DOPA on monoamine synaptic transmission in mouse brain slices. Application of L-DOPAaugmented the D2-receptor- mediated inhibitory postsynaptic current (IPSC) in dopamine neurons of the substantia nigra. This augmentation was largely due to dopamine release from 5-HT terminals. Selective optogenetic stimulation of 5-HT terminals evoked dopamine release, producing D2-receptor-mediated IPSCs following treatment with L-DOPA. In the dorsal raphe, L-DOPA produced a long-lasting depression of the 5-HT1Areceptor- mediated IPSC in 5-HT neurons. When D2 receptors were expressed in the dorsal raphe, application of L-DOPA resulted in a D2-receptor-mediated IPSC. Thus, treatment with L-DOPA caused ectopic dopamine release from 5-HT terminals and a loss of 5-HT-mediated synaptic transmission.

Original languageEnglish (US)
Pages (from-to)944-954
Number of pages11
JournalCell Reports
Volume12
Issue number6
DOIs
StatePublished - 2015

Fingerprint

Synaptic Transmission
Dopamine
Serotonin
Inhibitory Postsynaptic Potentials
Neurons
Parkinson Disease
Optogenetics
Dopaminergic Neurons
Substantia Nigra
Neurotransmitter Agents
Psychiatry
Comorbidity
Brain

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Depression of serotonin synaptic transmission by the dopamine Precursor L-DOPA. / Gantz, Stephanie C.; Levitt, Erica S.; Llamosas, Nerea; Neve, Kim; Williams, John.

In: Cell Reports, Vol. 12, No. 6, 2015, p. 944-954.

Research output: Contribution to journalArticle

Gantz, Stephanie C. ; Levitt, Erica S. ; Llamosas, Nerea ; Neve, Kim ; Williams, John. / Depression of serotonin synaptic transmission by the dopamine Precursor L-DOPA. In: Cell Reports. 2015 ; Vol. 12, No. 6. pp. 944-954.
@article{148163b6df9b496b9cfa989927c89230,
title = "Depression of serotonin synaptic transmission by the dopamine Precursor L-DOPA",
abstract = "Imbalance between the dopamine and serotonin (5-HT) neurotransmitter systems has been implicated in the comorbidity of Parkinson's disease (PD) and psychiatric disorders. L-DOPA, the leading treatment of PD, facilitates the production and release of dopamine. This study assessed the action of L-DOPA on monoamine synaptic transmission in mouse brain slices. Application of L-DOPAaugmented the D2-receptor- mediated inhibitory postsynaptic current (IPSC) in dopamine neurons of the substantia nigra. This augmentation was largely due to dopamine release from 5-HT terminals. Selective optogenetic stimulation of 5-HT terminals evoked dopamine release, producing D2-receptor-mediated IPSCs following treatment with L-DOPA. In the dorsal raphe, L-DOPA produced a long-lasting depression of the 5-HT1Areceptor- mediated IPSC in 5-HT neurons. When D2 receptors were expressed in the dorsal raphe, application of L-DOPA resulted in a D2-receptor-mediated IPSC. Thus, treatment with L-DOPA caused ectopic dopamine release from 5-HT terminals and a loss of 5-HT-mediated synaptic transmission.",
author = "Gantz, {Stephanie C.} and Levitt, {Erica S.} and Nerea Llamosas and Kim Neve and John Williams",
year = "2015",
doi = "10.1016/j.celrep.2015.07.005",
language = "English (US)",
volume = "12",
pages = "944--954",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Depression of serotonin synaptic transmission by the dopamine Precursor L-DOPA

AU - Gantz, Stephanie C.

AU - Levitt, Erica S.

AU - Llamosas, Nerea

AU - Neve, Kim

AU - Williams, John

PY - 2015

Y1 - 2015

N2 - Imbalance between the dopamine and serotonin (5-HT) neurotransmitter systems has been implicated in the comorbidity of Parkinson's disease (PD) and psychiatric disorders. L-DOPA, the leading treatment of PD, facilitates the production and release of dopamine. This study assessed the action of L-DOPA on monoamine synaptic transmission in mouse brain slices. Application of L-DOPAaugmented the D2-receptor- mediated inhibitory postsynaptic current (IPSC) in dopamine neurons of the substantia nigra. This augmentation was largely due to dopamine release from 5-HT terminals. Selective optogenetic stimulation of 5-HT terminals evoked dopamine release, producing D2-receptor-mediated IPSCs following treatment with L-DOPA. In the dorsal raphe, L-DOPA produced a long-lasting depression of the 5-HT1Areceptor- mediated IPSC in 5-HT neurons. When D2 receptors were expressed in the dorsal raphe, application of L-DOPA resulted in a D2-receptor-mediated IPSC. Thus, treatment with L-DOPA caused ectopic dopamine release from 5-HT terminals and a loss of 5-HT-mediated synaptic transmission.

AB - Imbalance between the dopamine and serotonin (5-HT) neurotransmitter systems has been implicated in the comorbidity of Parkinson's disease (PD) and psychiatric disorders. L-DOPA, the leading treatment of PD, facilitates the production and release of dopamine. This study assessed the action of L-DOPA on monoamine synaptic transmission in mouse brain slices. Application of L-DOPAaugmented the D2-receptor- mediated inhibitory postsynaptic current (IPSC) in dopamine neurons of the substantia nigra. This augmentation was largely due to dopamine release from 5-HT terminals. Selective optogenetic stimulation of 5-HT terminals evoked dopamine release, producing D2-receptor-mediated IPSCs following treatment with L-DOPA. In the dorsal raphe, L-DOPA produced a long-lasting depression of the 5-HT1Areceptor- mediated IPSC in 5-HT neurons. When D2 receptors were expressed in the dorsal raphe, application of L-DOPA resulted in a D2-receptor-mediated IPSC. Thus, treatment with L-DOPA caused ectopic dopamine release from 5-HT terminals and a loss of 5-HT-mediated synaptic transmission.

UR - http://www.scopus.com/inward/record.url?scp=84947022928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947022928&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2015.07.005

DO - 10.1016/j.celrep.2015.07.005

M3 - Article

C2 - 26235617

AN - SCOPUS:84947022928

VL - 12

SP - 944

EP - 954

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 6

ER -